Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure and Function of Platelets01:18

Structure and Function of Platelets

The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000 platelets, with...
Formation of the Platelet Plug01:22

Formation of the Platelet Plug

The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Long covid and general practice: a survey of patients in the Republic of Ireland.

Irish journal of medical science·2026
Same author

Refining inflammatory profiles linked to cardiometabolic outcomes in people with HIV using recursive feature addition modelling.

Clinical and translational medicine·2026
Same author

Perinatal transmission of <i>Borrelia burgdorferi:</i> advancing scientific and clinical understanding of Lyme disease in pregnancy.

Frontiers in medicine·2026
Same author

Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approach.

PLoS computational biology·2026
Same author

Ultrarare Variants in DNA Damage Repair and Mitochondrial Genes in Pediatric Acute-Onset Neuropsychiatric Syndrome and Acute Behavioral Regression in Neurodevelopmental Disorders.

Developmental neuroscience·2026
Same author

Immunogenicity, reactogenicity, and safety to assess booster vaccinations with BNT162b2 or double-dose mRNA-1273 in adults ≥75 years (EU-COVAT-1-AGED)-final report.

International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases·2026

Related Experiment Video

Updated: Jun 16, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

Platelet function and HIV: a case-control study.

Claudette S Satchell1, Aoife G Cotter, Eileen F O'Connor

  • 1School of Medicine and Medical Sciences, University College Dublin, Ireland. claudette.satchell@ucd.ie

AIDS (London, England)
|February 24, 2010
PubMed
Summary

HIV infection alters platelet reactivity, increasing cardiovascular disease risk. Further research is needed to understand these platelet function defects and their link to cardiovascular issues in HIV patients.

More Related Videos

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Related Experiment Videos

Last Updated: Jun 16, 2026

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
06:46

Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals

Published on: January 5, 2016

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection
08:14

An In Vitro Model for Measuring Immune Responses to Malaria in the Context of HIV Co-infection

Published on: October 6, 2015

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
09:54

Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models

Published on: December 3, 2019

Area of Science:

  • Cardiovascular Science
  • Infectious Disease
  • Hematology

Background:

  • Cardiovascular disease (CVD) and myocardial infarction (MI) are significant concerns in HIV-infected populations.
  • Platelets play a crucial role in arterial thrombosis, a key factor in MI.
  • Limited data exists on platelet function in individuals with HIV infection.

Purpose of the Study:

  • To investigate and compare platelet reactivity in HIV-infected and HIV-negative individuals.
  • To determine if HIV infection is associated with altered platelet function.

Main Methods:

  • A case-control study design was employed.
  • Twenty HIV-infected (HIVpos) and 20 age/sex-matched HIV-negative (HIVneg) individuals participated.
  • Platelet aggregation was measured using light absorbance in response to various agonists (epinephrine, collagen, thrombin receptor-activating peptide, ADP).

Main Results:

  • HIVpos patients exhibited altered platelet reactivity compared to HIVneg individuals across all tested agonists.
  • Platelets from HIVpos patients showed increased reactivity to epinephrine.
  • Conversely, HIVpos patients displayed reduced platelet aggregation in response to thrombin receptor-activating peptide, ADP, and collagen.

Conclusions:

  • Significant differences in platelet responses suggest underlying defects in platelet function associated with HIV infection.
  • Further investigation is warranted to explore the role of antiretroviral therapy (ART) and the direct link between platelet dysfunction and increased CVD risk in HIV-positive individuals.